Potential Effect of L-Carnitine on the Prevention of Myocardial Injury After Coronary Artery Bypass Graft Surgery

Overview

Journal J Tehran Heart Cent

Publisher Tehran University of Medical Sciences

Specialty Cardiology & Vascular Diseases

Date 2015 Jun 26

PMID 26110005

Citations 2

Authors

Farzaneh Dastan

Azita Hajhossein Talasaz

Mojtaba Mojtahedzadeh

Abbasali Karimi

Abbas Salehiomran

Payvand Bina

Arash Jalali

Zahra Aghaie

Affiliations

Soon will be listed here.

Abstract

Background: L-carnitine has been demonstrated to confer cardiac protection against ischemia reperfusion injury in animals. This study evaluates the effects of L-carnitine administration on cardiac biomarkers after coronary artery bypass graft (CABG) surgery.

Methods: One hundred thirty-four patients undergoing elective CABG surgery, without a history of myocardial ischemia or previous L-carnitine treatment, were enrolled and randomly assigned to an L-carnitine group ([n = 67], 3000 mg/d, started 2 days preoperatively and continued for 2 days after surgery) or a control group (n = 67). CK-MB (creatine kinase, muscle-brain subunits) and troponin T (TnT) levels were assessed in all the patients before surgery as baseline levels and at 8 and 24 hours postoperatively.

Results: Our study included 134 patients (99 [73.8%] males) at a mean ± SD age of 59.94 ± 8.61 years who were candidates for CABG and randomized them into control or L-carnitine groups. The baseline demographic characteristics, including age (60.01 ± 9.23 in the L-carnitine group vs. 59.88 ± 7.98 in the control group) and sex (54 [80.6%] in the L-carnitine group vs. 45 [67.2%] in the control group) did not show any significant differences (p value=0.93 and 0.08, respectively). Patients in the L-carnitine group had lower levels of CK-MB (mean ± SD, 25.06 ± 20.29 in the L-carnitine group vs. 24.26 ± 14.61 in the control group), but the difference was not significant (p value = 0.28). TnT levels also showed no significant differences between the two groups (399.50 ± 378.91 in the L-carnitine group vs. 391.48 ± 222.02 in the control group; p value = 0.34).

Conclusion: In this population of intermediate- to high-risk patients undergoing CABG surgery, L-carnitine did not reduce CK-MB and TnT levels.

Citing Articles

The Potential Effect of Intravenous Calcitriol on the Ischemia-Reperfusion Process and Inflammatory Biomarkers in Patients Following Percutaneous Coronary Intervention (PCI).

Dastan F, Salamzadeh J, Alipour-Parsa S, Kashani B, Hashempour M Iran J Pharm Res. 2020; 18(Suppl1):282-290.

PMID: 32802107 PMC: 7393057. DOI: 10.22037/ijpr.2019.112469.13778.

Simultaneous Determination of Isoniazid, Pyrazinamide and Rifampin in Human Plasma by High-performance Liquid Chromatography and UV Detection.

Dasht Bozorg B, Goodarzi A, Fahimi F, Tabarsi P, Shahsavari N, Kobarfard F Iran J Pharm Res. 2020; 18(4):1735-1741.

PMID: 32184842 PMC: 7059034. DOI: 10.22037/ijpr.2019.1100849.

References

Iliceto S, Scrutinio D, Bruzzi P, DAmbrosio G, Boni L, Di Biase M . Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. J Am Coll Cardiol. 1995; 26(2):380-7. DOI: 10.1016/0735-1097(95)80010-e. View

Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N . Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007; 117(4):e25-146. DOI: 10.1161/CIRCULATIONAHA.107.187998. View

Theroux P, Chaitman B, Danchin N, Erhardt L, Meinertz T, Schroeder J . Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation. 2000; 102(25):3032-8. DOI: 10.1161/01.cir.102.25.3032. View

Plume S, OConnor G, Olmstead E . As originally published in 1994: Changes in patients undergoing coronary artery bypass grafting: 1987-1990. Updated in 2000. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg. 2001; 72(1):314-5. DOI: 10.1016/s0003-4975(01)02453-5. View

Bremer J . Carnitine--metabolism and functions. Physiol Rev. 1983; 63(4):1420-80. DOI: 10.1152/physrev.1983.63.4.1420. View

Cui J, Das D, Bertelli A, Tosaki A . Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts. Mol Cell Biochem. 2003; 254(1-2):227-34. DOI: 10.1023/a:1027368018064. View

Lango R, Smolenski R, NARKIEWICZ M, Suchorzewska J, Lysiak-Szydlowska W . Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc Res. 2001; 51(1):21-9. DOI: 10.1016/s0008-6363(01)00313-3. View

El Banani H, Bernard M, Cozzone P, James F, Feuvray D . Ionic and metabolic imbalance as potential factors of ischemia reperfusion injury. Am J Cardiol. 1998; 82(5A):25K-29K. DOI: 10.1016/s0002-9149(98)00534-7. View

Yellon D, Hausenloy D . Myocardial reperfusion injury. N Engl J Med. 2007; 357(11):1121-35. DOI: 10.1056/NEJMra071667. View

10.

Lopaschuk G . Regulation of carbohydrate metabolism in ischemia and reperfusion. Am Heart J. 2000; 139(2 Pt 3):S115-9. DOI: 10.1067/mhj.2000.103919. View

11.

Mangano D, Miao Y, Tudor I, Dietzel C . Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine. J Am Coll Cardiol. 2006; 48(1):206-14. DOI: 10.1016/j.jacc.2006.04.044. View

12.

Brener S, Lytle B, Schneider J, Ellis S, Topol E . Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol. 2002; 40(11):1961-7. DOI: 10.1016/s0735-1097(02)02538-x. View

13.

Katus H, Remppis A, Neumann F, Scheffold T, DIEDERICH K, Vinar G . Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991; 83(3):902-12. DOI: 10.1161/01.cir.83.3.902. View

14.

Desai N, Cohen E, Naylor C, Fremes S . A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med. 2004; 351(22):2302-9. DOI: 10.1056/NEJMoa040982. View

15.

EDWARDS F, Clark R, Schwartz M . Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience. Ann Thorac Surg. 1994; 57(1):12-9. DOI: 10.1016/0003-4975(94)90358-1. View

16.

Liedtke A, Demaison L, Nellis S . Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol. 1988; 255(1 Pt 2):H169-76. DOI: 10.1152/ajpheart.1988.255.1.H169. View

17.

Suzuki Y, Narita M, Yamazaki N . Effects of L-carnitine on arrhythmias during hemodialysis. Jpn Heart J. 1982; 23(3):349-59. DOI: 10.1536/ihj.23.349. View

18.

Eagle K, Guyton R, Davidoff R, Edwards F, Ewy G, Gardner T . ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass.... Circulation. 2004; 110(14):e340-437. View

19.

Costa M, Carere R, Lichtenstein S, Foley D, de Valk V, Lindenboom W . Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation. 2001; 104(22):2689-93. DOI: 10.1161/hc4701.099789. View

20.

Gerhardt W, Katus H, Ravkilde J, Hamm C, Jorgensen P, Peheim E . S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem. 1991; 37(8):1405-11. View